ArticleFrontiers in medicine2025
Sexual dysfunction and quality of life in cervical and endometrial cancer patients before and after low-dose-rate brachytherapy: a cohort study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Family and sexual functioning among women diagnosed with cervical cancer in Urban Ghana: A mixed-methods study.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Research on low-dose-rate (LDR) brachytherapy for gynecological cancer primarily examines treatment toxicity while overlooking aspects such as sexual desire, arousal, orgasm, satisfaction, and overall quality of life. We assessed sexual function and quality of life in patients with cervical and endometrial cancer before and after LDR brachytherapy, identifying factors related to sexual dysfunction and good quality of life 3-6 months after brachytherapy. Materials and methods: We prospectively followed a cohort of patients with a histopathological diagnosis of cervical and endometrial cancer who were treated with LDR intracavitary brachytherapy ( Results: Sexual dysfunction was observed in 14.4% of individuals, with 30% already affected at baseline. Higher education was associated with a decreased likelihood of developing or maintaining sexual dysfunction (OR, 0.10; 95% CI, 0.01-0.97). Physical wellbeing improved after treatment, with scores increasing from 69.3 to 78.7 ( Conclusion: Over 10% of patients experienced sexual dysfunction, with physical wellbeing being the only area that showed improvement after treatment. Research in this area enhances awareness and understanding of how healthcare providers can better support sexual and health-related wellbeing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.